Most diabetic patients describe moderate to severe pain symptoms whose pharmacological
treatment is palliative and poorly effective. Cannabidiol (CBD) has shown promising results …

Cannabidiol, the major psycho-inactive component of cannabis, has substantial anti-
inflammatory and immunomodulatory effects. This study investigated its therapeutic potential …

Cannabis has a long history of medical use. Although there are many cannabinoids present
in cannabis, Δ9tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) are the two …

The most frequently reported use of medical marijuana is for pain relief. However, its
psychoactive component Δ9-tetrahydrocannabinol (THC) causes significant side effects …

Neuropathic pain remains prevalent and challenging to manage and is often comorbid with
depression and anxiety. The new approach that simultaneously targets neuropathic pain …

Cannabis has been used for centuries to treat pain. The antinociceptive activity of
tetrahydrocannabinol (THC) or cannabidiol (CBD) has been widely studied. However, the …

The nonpsychoactive phytocannabinoid cannabidiol (CBD) has been shown to have
analgesic effects in animal studies but little is known about its mechanism of action. We …

Cannabis and its psychoactive constituent D9-tetrahydrocannabinol (THC) have efficacy
against neuropathic pain, however, this is hampered by their side effects. It has been …

Preclinical studies have demonstrated the analgesic potential of cannabidiol (CBD). Those
suggesting an effect on pain-processing receptors have brought CBD back into focus. This …

Clinical studies indicate that cannabidiol (CBD), the primary nonaddictive component of
cannabis that interacts with the serotonin (5-HT) 1A receptor, may possess analgesic and …